Modalities, Payloads & Drug Carriers

Expertise to Overcome Targeting and Biodistribution Barriers

Phosphorex brings deep expertise across advanced therapeutic modalities, diverse payloads, and leading particle-based drug carriers. From nucleic acids and gene-editing systems to peptides, proteins, and small molecules, we engineer tailored delivery strategies that overcome poor targeting and inefficient intracellular delivery. Leveraging LNPs, polymeric nanoparticles, polymeric microspheres, and hybrid systems, we deliver scalable solutions for emerging therapeutic classes while collaborating with clients to effectively address challenges such as potency, immunogenicity risks, and poor biodistribution.

Connect with Drug Delivery Experts

Targeted Delivery Solutions Spanning Diverse Therapeutic Modalities

Across cell therapy, gene therapy, vaccines, immuno-oncology, and long-acting injectables, Phosphorex engineers particle-based delivery systems that enable precise targeting, efficient intracellular delivery, and sustained therapeutic performance across a wide range of clinical applications.

ex vivo
Cell Therapy

Advanced LNP platforms enabling efficient delivery of CAR constructs and gene editing cargos into lymphocytes for scalable cell therapy development.

in vivo
Cell Engineering

Targeted LNP systems enabling precise CAR gene delivery, efficient intracellular expression, and controlled biodistribution for in vivo immune cell reprogramming.

Gene Therapy

Expert LNP formulation for gene therapy, encapsulating and delivering CRISPR-Cas9 while overcoming degradation and immune recognition.

Gene Silencing

Expert delivery of siRNA and ASOs via LNPs, polymeric nanoparticles, and lipid-polymer hybrids for targeted gene silencing.

Vaccines

Expertly designed nanoparticles enhancing stability, antigen presentation, and adjuvanticity for targeted immune cell delivery and robust pathogen protection.

Immuno-oncology

Our nanoparticles protect immune-modulating cargo and drive targeted accumulation in the tumor microenvironment to enhance anticancer immune activation.

Ligand Conjugation

Conjugation of targeting ligands (VHH, mAb, scFv, Fab, peptides) to lipid and polymeric nanoparticles enables precise cellular targeting, maximizes therapeutic impact, and reduces off-target effects.

Long-Acting Injectables

Expert polymeric microsphere design enabling sustained small molecule, peptide, and protein release for long-acting injectable applications.

Optimized Nanoparticles for Diverse Therapeutic Payloads

Our scientists are industry leaders designing LNP, polymeric nanoparticle, polymeric microsphere, and lipid-polymer hybrid delivery systems to maximize stability, targeting precision, and therapeutic performance for a range of therapeutic payloads.

  • siRNA
  • ASO
  • mRNA
  • DNA
  • Small molecules
  • Peptides
  • Proteins
Scientists working in laboratory on optimized nanoparticles

Core Drug Delivery Solutions

Phosphorex offers expertise in the three dominant non-viral drug delivery platforms, tailoring them to address program-specific needs.

Comprehensive Drug Carriers Engineered for Clinical Success

We design advanced drug carrier systems that protect fragile biologics, control release profiles, and enable precise targeting in complex biological environments. With over 20 years of experience, we develop tailored delivery platforms engineered to enhance stability, optimize biodistribution, and maximize therapeutic efficacy while minimizing off-target effects. Our drug carrier expertise includes our core drug delivery solutions, as well as more specialized options:

  • Lipid Nanoparticles
  • Liposomes
  • Polymeric Nanoparticles
  • Polymeric Microspheres
  • Micelles
  • Lipid-polymer Hybrid
  • Polyplexes

THE PHOSPHOREX DRUG DELIVERY ENGINE IN PRACTICE

Long-Acting Peptide Formulation Advanced from Optimization to Phase I

Problem

A partner developing a long-acting peptide therapy for a rare autoimmune disease faced significant formulation and scalability challenges that threatened progress toward clinical development. Existing formulation approaches failed to meet loading, release, and manufacturability requirements needed for IND-enabling studies and clinical supply.

Solution

Phosphorex re-engineered the partner’s formulation, resolving critical technical limitations and establishing a robust, scalable process. The optimized system achieved high peptide loading and encapsulation efficiency with minimal burst release. Phosphorex successfully scaled the formulation and process beyond 300-gram scale, produced GLP preclinical batches to support IND-enabling studies, and executed seamless tech transfer to a GMP manufacturing site.

Outcome

Clinical-grade material was manufactured and released, enabling initiation of a Phase I clinical trial and positioning the program for continued clinical advancement.

Modalities, Payloads & Drug Carriers FAQs

Updates & Expertise

Leveraging Advanced Drug Delivery Systems to Improve Clinical Viability
Articles

Leveraging Advanced Drug Delivery Systems to Improve Clinical Viability

Development of Long-Acting Injectable Microspheres
Case Studies

Development of Long-Acting Injectable Microspheres

Post-Assembly Functionalization of Maleimide-Derivatized Lipid Nanoparticles with Peptide and Antibody Ligands via Thiol-Maleimide Conjugation Chemistry
Technical Bulletins

Post-Assembly Functionalization of Maleimide-Derivatized Lipid Nanoparticles with Peptide and Antibody Ligands via Thiol-Maleimide Conjugation Chemistry

Subject Matter Expert Video Series | Iro Vinales, Ph.D.
Videos

Subject Matter Expert Video Series | Iro Vinales, Ph.D.

Webinar on Demand | From Bench to Scale: Scaling Biodegradable mRNA Lipid Nanoparticle for Clinical Success
Webinars

Webinar on Demand | From Bench to Scale: Scaling Biodegradable mRNA Lipid Nanoparticle for Clinical Success

Ready to Engineer Particles for Precision Drug Delivery?

Ready to Engineer Particles for Precision Drug Delivery?

Partner with Phosphorex to transform your therapeutic vision into a precisely designed, clinically viable drug delivery solution.

Let’s Get Started